Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...
As flu season returns and vaccines are rolled out, researchers at the Allen Institute are uncovering why vaccines don’t work ...
A Medical Breakthrough Saved Millions of Lives During COVID. Why Are We Turning Our Backs on It Now?
By halting funding for mRNA research, the government is endangering America’s health and leadership in biomedical innovation.
CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR RNA-guided cleavage. Type V CRISPR-Cas (Cas12) systems, in particular, ...
Nex-z is one of two late-stage projects on the go at Intellia, a specialist in CRISPR gene-editing co-founded by Nobel Prize ...
The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research rattled scientists working inside and outside industry. The cuts raised alarm ...
CRISPR powers everything from gene editing to rapid diagnostics, but how did one of its most versatile branches arise? A new Cell study, “Functional RNA splitting drove the evolutionary emergence of ...
The codebreaking works like this. The GenomePAM method maps CRISPR's passwords directly in human cells. Instead of relying on artificial systems that are often limited (e.g., testing 1 to 3 sequences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results